Interaction of PD-1 with its ligands leads to an inhibitory effect on the activation of T-lymphocytes, an increase in the number of Foxp3+ T-regulatory cells and inducing of apoptosis of CD8+ cytotoxic T-lymphocytes, which allows the tumor to “escape” the immune response [9]. Here, PDCD1 is linked to neoplasm.